Novo Nordisk CEO on treating diabetes and obesity, and challenges facing the industry

Novo Nordisk CEO Lars Jorgensen discusses the company's latest results, developing and supplying the world with medication and devices to treat diabetes, and logistical challenges facing the company and the industry. For access to live and exclusive video from CNBC subscribe to CNBC PRO: cnb.cx/2NGeIvi
» Subscribe to CNBC TV: cnb.cx/Subscri...
» Subscribe to CNBC: cnb.cx/Subscri...
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: www.cnbc.com/2...
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedI...
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/Instagr...
www.cnbc.com/s...
#CNBC
#CNBCTV

[@FireEverLiving]

This class of drugs (being developed by several companies) is really promising. They've been shown in trials to cut 15+lbs with few side effects, way better than e.g. alli. The key will be getting insurance to cover it broadly.

[@ChristopherWalkenPUA]

Drugs aren't needed for obesity... just eat vegetables and exercise.

[@VernCrisler]

You can be vegan and still develop diabetes and obesity,.

[@pomp4401]

Surprise - there are fat people who are lazy.

[@henryzhang9915]

This host needs to read more before asking.

[@VernCrisler]

Green energy...no wonder there's a shortage of Ozempic/Wegovy. Maybe windmills and waterfalls can get Novo Wokedisk up to the 18th century, but it doesn't get them anywhere near the 21st century.